180 Life Sciences Files 8-K with Financials

TL;DR

180 Life Sciences filed an 8-K with financials on Oct 16, 2024.

AI Summary

On October 16, 2024, 180 Life Sciences Corp. filed an 8-K report. The filing indicates that the company is providing financial statements and exhibits. No other specific events or financial details were disclosed in the provided text.

Why It Matters

This filing provides updated financial information and exhibits for 180 Life Sciences Corp., which is important for investors to assess the company's financial health and operational status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report containing financial statements and exhibits, with no immediate negative or positive news disclosed.

Key Players & Entities

• 180 Life Sciences Corp. (company) — Registrant
• October 16, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-38105 (identifier) — Commission File Number
• 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto, CA (address) — Business Address

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Mar

Filing Documents

• ea0217703-8k_180life.htm (8-K) — 33KB
• ea021770301ex99-1_180life.htm (EX-99.1) — 76KB
• 0001213900-24-087976.txt ( ) — 346KB
• atnf-20241016.xsd (EX-101.SCH) — 4KB
• atnf-20241016_def.xml (EX-101.DEF) — 26KB
• atnf-20241016_lab.xml (EX-101.LAB) — 36KB
• atnf-20241016_pre.xml (EX-101.PRE) — 25KB
• ea0217703-8k_180life_htm.xml (XML) — 6KB

01 Other Events

Item 8.01 Other Events On October 16, 2024, 180 Life Sciences Corp. (the " Company ") issued a press release including a letter to stockholders from the Company's Interim Chief Executive Officer, Blair Jordan. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued dated October 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Forward- Looking Statements This Current Report on Form 8-K and Exhibit 99.1 attached, contain forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act, as amended. Forward-looking statements are based on management's current expectations and are from those projected. These risks and uncertainties, many of which are beyond our control, include risks described in the section entitled " Risk Factors " and elsewhere in our Annual Reports on Form 10-K and in our other filings with the SEC, including, without limitation, our reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 16, 2024 180 LIFE SCIENCES CORP. By: /s/ Blair Jordan Name: Blair Jordan Title: Interim Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR